PrognomiQ
Dr. Lindpaintner serves as a Scientific and Clinical Advisor to PrognomiQ. He was most recently Chief Medical and Scientific Officer at InterVenn Biosciences. Previously, he was Vice President and Global Head, Human Genetics & Computational Medicine at Pfizer. He has also served as Chief Scientific Officer at Thermo Fisher Scientific, and as Chief Scientific Officer at SDIX. Earlier in his career, he was Vice President, Roche Center for Medical Genomics & Roche Distinguished Scientist at Roche Pharmaceuticals, and Associate Professor, Harvard University. Dr. Lindpaintner received his M.D. from Leopold-Franzens Universität Innsbruck, and a Masters of Public Health (M.P.H.) from Harvard. He is board certified in internal medicine, cardiology, and clinical and molecular genetics.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
PrognomiQ
1 followers
PrognomiQ aims to generate proteomic information with high accuracy, scale and speed. This proteomic data will be complemented with genomic, metabolomic and other health information to deliver first-in-class test products that enable early disease detection and treatment.